• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

叙事医学方法在糖尿病性黄斑水肿治疗中的应用:意大利经验。

The Narrative Medicine Approach in the Treatment of Diabetic Macular Edema: An Italian Experience.

机构信息

Department of Ophthalmology, University of Padova, 35128 Padova, Italy.

IRCCS-Fondazione Bietti, 00198 Rome, Italy.

出版信息

Int J Environ Res Public Health. 2022 Jul 30;19(15):9367. doi: 10.3390/ijerph19159367.

DOI:10.3390/ijerph19159367
PMID:35954724
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9368569/
Abstract

The study retraces the healthcare pathway of patients affected by diabetic macular edema (DME) through the direct voice of patients and caregivers by using a "patient journey" and narrative method approach. The mapping of the patient's journey was developed by a multidisciplinary board of health professionals and involved four Italian retina centers. DME patients on intravitreal injection therapy and caregivers were interviewed according to the narrative medicine approach. Narratives were analyzed through a quali-quantitative tool, as set by the narrative medicine method. The study involved four specialized retina centers in Italy and collected a total of 106 narratives, 82 from DME patients and 24 from caregivers. The narratives reported their difficulty in identifying the correct pathway of care because of a limited awareness of diabetes and its complications. Patients experienced reduced autonomy due to ocular complications. In the treatment of diabetes and its complications, a multidisciplinary approach currently appears to be missing. DME reduces the quality of life of affected patients. The narrative medicine approach offers qualitative and emotional patient-guided information. The patient journey provides all of those involved in the management of DME with flowcharts to refer to, identifying the critical points in the healthcare journey of DME patients to improve the management of the disease.

摘要

该研究通过使用“患者旅程”和叙述方法,直接听取患者和护理人员的意见,追溯受糖尿病性黄斑水肿(DME)影响的患者的医疗保健路径。患者旅程的绘制由一个多学科的医疗保健专业人员委员会开发,并涉及四个意大利视网膜中心。根据叙述医学方法,对接受玻璃体内注射治疗的 DME 患者和护理人员进行了访谈。通过叙述医学方法设定的定性-定量工具对叙述进行了分析。该研究涉及意大利的四个专门的视网膜中心,共收集了 106 个叙述,其中 82 个来自 DME 患者,24 个来自护理人员。这些叙述报告说,由于对糖尿病及其并发症的认识有限,他们难以确定正确的护理途径。眼部并发症使患者的自主性降低。在糖尿病及其并发症的治疗中,目前似乎缺少多学科方法。DME 降低了受影响患者的生活质量。叙述医学方法提供了定性和情感的以患者为导向的信息。患者旅程为参与 DME 管理的所有人提供了流程图,以确定 DME 患者医疗保健旅程中的关键点,从而改善疾病的管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a22a/9368569/323b410789cb/ijerph-19-09367-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a22a/9368569/0358791e7c1c/ijerph-19-09367-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a22a/9368569/e7b2c91a72c9/ijerph-19-09367-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a22a/9368569/3919a6a263d7/ijerph-19-09367-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a22a/9368569/966e732afd2d/ijerph-19-09367-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a22a/9368569/323b410789cb/ijerph-19-09367-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a22a/9368569/0358791e7c1c/ijerph-19-09367-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a22a/9368569/e7b2c91a72c9/ijerph-19-09367-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a22a/9368569/3919a6a263d7/ijerph-19-09367-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a22a/9368569/966e732afd2d/ijerph-19-09367-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a22a/9368569/323b410789cb/ijerph-19-09367-g005.jpg

相似文献

1
The Narrative Medicine Approach in the Treatment of Diabetic Macular Edema: An Italian Experience.叙事医学方法在糖尿病性黄斑水肿治疗中的应用:意大利经验。
Int J Environ Res Public Health. 2022 Jul 30;19(15):9367. doi: 10.3390/ijerph19159367.
2
Real-life patient journey in neovascular age-related macular degeneration: a narrative medicine analysis in the Italian setting.新生血管性年龄相关性黄斑变性患者的真实就医历程:意大利背景下的叙事医学分析
Eye (Lond). 2022 Jan;36(1):182-192. doi: 10.1038/s41433-021-01470-9. Epub 2021 Mar 5.
3
Practical Lessons from Protocol I for the Management of Diabetic Macular Edema.《糖尿病性黄斑水肿管理的第一议定书实用经验》
Dev Ophthalmol. 2017;60:91-108. doi: 10.1159/000459692. Epub 2017 Apr 20.
4
Expectations and fears of patients with diabetes and macular edema treated by intravitreal injections.糖尿病并黄斑水肿患者接受眼内注射治疗的期望和担忧。
Acta Diabetol. 2020 Sep;57(9):1081-1091. doi: 10.1007/s00592-020-01513-9. Epub 2020 Apr 9.
5
Diabetic macular edema: changing treatment paradigms.糖尿病性黄斑水肿:不断变化的治疗模式
Curr Opin Ophthalmol. 2014 Nov;25(6):502-7. doi: 10.1097/ICU.0000000000000102.
6
[Intravitreal triamcinolone combined with grid laser photocoagulation for patients with cystoid macular edema and advanced diabetic retinopathy: pilot study].玻璃体内注射曲安奈德联合格栅样激光光凝治疗黄斑囊样水肿合并晚期糖尿病视网膜病变患者:初步研究
Arch Soc Esp Oftalmol. 2013 Oct;88(10):373-9. doi: 10.1016/j.oftal.2013.01.020. Epub 2013 May 29.
7
[Combination therapy in patients with concomitant macular edema and proliferative diabetic retinopathy].[黄斑水肿合并增殖性糖尿病视网膜病变患者的联合治疗]
Vestn Oftalmol. 2019;135(6):67-72. doi: 10.17116/oftalma201913506167.
8
Considerations for management of patients with diabetic macular edema: Optimizing treatment outcomes and minimizing safety concerns through interdisciplinary collaboration.糖尿病性黄斑水肿患者的管理考量:通过跨学科协作优化治疗效果并将安全问题降至最低。
Diabetes Res Clin Pract. 2017 Apr;126:1-9. doi: 10.1016/j.diabres.2017.01.013. Epub 2017 Jan 29.
9
Combined therapy for diabetic macular edema.糖尿病性黄斑水肿的联合治疗
Middle East Afr J Ophthalmol. 2013 Oct-Dec;20(4):315-20. doi: 10.4103/0974-9233.120014.
10
Economic Aspects in the Management of Diabetic Macular Edema in Italy.意大利糖尿病性黄斑水肿管理中的经济问题。
Front Public Health. 2022 Jul 22;10:938987. doi: 10.3389/fpubh.2022.938987. eCollection 2022.

引用本文的文献

1
Pharmaceutical Humanities and Narrative Pharmacy: An Emerging New Concept in Pharmacy.药学人文与叙事药学:药学领域中一个新兴的概念。
Pharmaceuticals (Basel). 2025 Jan 3;18(1):48. doi: 10.3390/ph18010048.
2
Identification of Barriers for Active Disease Management and of Medication-Related Problems through Therapeutic Patient Education in Older Home-Care Patients.通过对老年居家护理患者进行治疗性患者教育来识别积极疾病管理的障碍和药物相关问题。
Healthcare (Basel). 2024 Jan 17;12(2):231. doi: 10.3390/healthcare12020231.
3
Intravitreal DEX Implant for the Treatment of Diabetic Macular Edema: A Review of National Consensus.

本文引用的文献

1
The prevalence of anxiety symptoms and disorders among ophthalmic disease patients.眼科疾病患者中焦虑症状和障碍的患病率。
Ther Adv Ophthalmol. 2022 Apr 19;14:25158414221090100. doi: 10.1177/25158414221090100. eCollection 2022 Jan-Dec.
2
Reporting of patient journey mapping in current literature: a scoping review protocol.报告当前文献中患者旅程图绘制的情况:范围综述方案。
JBI Evid Synth. 2022 May 1;20(5):1361-1368. doi: 10.11124/JBIES-21-00226.
3
Subthreshold Micropulse Laser Modulates Retinal Neuroinflammatory Biomarkers in Diabetic Macular Edema.
玻璃体内地塞米松植入物治疗糖尿病性黄斑水肿:一项全国性共识综述
Pharmaceutics. 2023 Oct 13;15(10):2461. doi: 10.3390/pharmaceutics15102461.
阈下微脉冲激光调节糖尿病性黄斑水肿中的视网膜神经炎症生物标志物。
J Clin Med. 2021 Jul 15;10(14):3134. doi: 10.3390/jcm10143134.
4
A Whole Other Story: Interpreting Narrative Medicine.完全不同的故事:解读叙事医学
Glob Adv Health Med. 2021 Jul 6;10:21649561211031880. doi: 10.1177/21649561211031880. eCollection 2021.
5
Intraocular fluid biomarkers (liquid biopsy) in human diabetic retinopathy.人糖尿病性视网膜病变的眼内液生物标志物(液体活检)。
Graefes Arch Clin Exp Ophthalmol. 2021 Dec;259(12):3549-3560. doi: 10.1007/s00417-021-05285-y. Epub 2021 Jul 3.
6
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis.全球糖尿病视网膜病变的患病率及 2045 年预期负担的系统评价和荟萃分析。
Ophthalmology. 2021 Nov;128(11):1580-1591. doi: 10.1016/j.ophtha.2021.04.027. Epub 2021 May 1.
7
Real-life patient journey in neovascular age-related macular degeneration: a narrative medicine analysis in the Italian setting.新生血管性年龄相关性黄斑变性患者的真实就医历程:意大利背景下的叙事医学分析
Eye (Lond). 2022 Jan;36(1):182-192. doi: 10.1038/s41433-021-01470-9. Epub 2021 Mar 5.
8
Update on Screening for Sight-Threatening Diabetic Retinopathy.筛查威胁视力的糖尿病视网膜病变进展。
Ophthalmic Res. 2019;62(4):218-224. doi: 10.1159/000499539. Epub 2019 May 27.
9
Diabetic Retinopathy Screening: A Systematic Review on Patients' Non-Attendance.糖尿病视网膜病变筛查:患者不依从性的系统评价。
Int J Environ Res Public Health. 2018 Jan 19;15(1):157. doi: 10.3390/ijerph15010157.
10
Mechanisms of macular edema: Beyond the surface.黄斑水肿的机制:不止于表面。
Prog Retin Eye Res. 2018 Mar;63:20-68. doi: 10.1016/j.preteyeres.2017.10.006. Epub 2017 Nov 7.